PPT-August 28, 2022 NCT04304534

John H Alexander MD MHS on behalf of the PACIFICAMI Steering Committee and Investigators Efficacy and Safety of the Oral Factor XIa Inhibitor Asundexian Added to

factor asundexian patients xia asundexian factor xia patients bleeding dose study drug phase placebo antiplatelet fxia dual acute specific

Presentation Embed Code

<iframe width="560" height="315" src="https://www.docslides.com/embed/1036661" frameborder="0" allowfullscreen></iframe>

Download Presentation

Download Presentation The PPT/PDF document "August 28, 2022 NCT04304534" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.